Heron Therapeutics (HRTX) Notes Payables (2011 - 2025)
Heron Therapeutics' (HRTX) quarterly Notes Payables came in at $149.8 million in Q2 2025, up 1882.87% quarter-over-quarter from $7.6 million in Q1 2021.
Powered by 
Analysis
Heron Therapeutics (HRTX) Notes Payables (2011 - 2025) Analysis & Trends
Heron Therapeutics (HRTX) has reported Notes Payables for 12 consecutive years, with $149.8 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Notes Payables changed N/A year-over-year to $149.8 million; the trailing twelve-month figure through Jun 2025 stood at $149.8 million (changed N/A YoY), and the FY2020 full-year result was $7.1 million, up 25.41% from the prior year.
- Notes Payables improved to $149.8 million in Q2 2025 per HRTX's latest filing, from $7.6 million in the prior quarter.
- Across five years, Notes Payables topped out at $149.8 million in Q2 2025 and bottomed at $7.6 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.59 Bn | 192.60 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.21 Bn | 177.03 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.41 Bn | 123.56 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.94 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.41 Bn | 1.37 Bn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.83 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn |
| 10 | Heron Therapeutics | 61.69 Mn | 19.02 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 149.81 Mn |
| Mar 31, 2021 | 7.56 Mn |
| Dec 31, 2020 | 7.05 Mn |
| Sep 30, 2020 | 6.64 Mn |
| Jun 30, 2020 | 6.27 Mn |
| Mar 31, 2020 | 5.93 Mn |
| Dec 31, 2019 | 5.62 Mn |
| Sep 30, 2019 | 5.35 Mn |
| Jun 30, 2019 | 5.08 Mn |
| Mar 31, 2019 | 4.82 Mn |
| Dec 31, 2018 | 4.57 Mn |
| Sep 30, 2018 | 4.34 Mn |
| Jun 30, 2018 | 25.00 Mn |
| Mar 31, 2018 | 25.00 Mn |
| Dec 31, 2017 | 25.00 Mn |
| Sep 30, 2017 | 3.48 Mn |
| Jun 30, 2017 | 3.29 Mn |
| Mar 31, 2017 | 3.10 Mn |
| Dec 31, 2016 | 2.91 Mn |
| Sep 30, 2016 | 2.73 Mn |